Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R Feeney

Showing results (61-70 of 68) with videos related to

Pageof 7
Sort By:
You have reached the last page of results.This site can display upto 68 results.
Microbes and Infection|November 9, 2023
Associations between host microbiome and inflammation suggest role for host microbiome in driving COVID-19 disease severityRachel MacCann, Tarini Shankar Ghosh, Alejandro Abner Garcia Leon, et al.
Ebiomedicine|February 23, 2025
Development and validation of a quantitative Orthopoxvirus immunoassay to evaluate and differentiate serological responses to Mpox infection and vaccinationJoanne Byrne, Gurvin Saini, Alejandro Garcia-Leon, et al.
Heliyon|August 15, 2024
Early inflammatory profiles predict maximal disease severity in COVID-19: An unsupervised cluster analysisGrace Kenny, Gurvin Saini, Colette Marie Gaillard, et al.
Open Forum Infectious Diseases|September 29, 2025
Antibody Responses are Sustained 2 Years Post-Mpox Infection but not Following Modified Vaccinia Ankara-Bavarian Nordic VaccinationJoanne Byrne, Alejandro Garcia-Leon, Aisling Murphy, et al.
The Journal of Infectious Diseases|June 6, 2018
Macrophage Activation Marker Soluble CD163 Is a Dynamic Marker of Liver Fibrogenesis in Human Immunodeficiency Virus/Hepatitis C Virus CoinfectionAnna Lidofsky, Jacinta A Holmes, Eoin R Feeney, et al.
Journal of Immunology (Baltimore, Md. : 1950)|May 23, 2025
Specific thresholds of circulating antibody titers predict against infection and reduced disease severity in SARS-CoV-2 close contactsJoanne Byrne, Colette Marie Gaillard, Lili Gu, et al.
Frontiers in Immunology|October 2, 2024
Robust and persistent B-cell responses following SARS-CoV-2 vaccine determine protection from SARS-CoV-2 infectionJoanne Byrne, Lili Gu, Alejandro Garcia-Leon, et al.
Nature Communications|November 3, 2023
Distinct receptor binding domain IgG thresholds predict protective host immunity across SARS-CoV-2 variants and timeGrace Kenny, Sophie O'Reilly, Neil Wrigley Kelly, et al.
Pageof 7

Showing results (61-70 of 68) with videos related to

Sort By:
Pageof 7
You have reached the last page of results.This site can display upto 68 results.
Microbes and Infection|November 9, 2023
Associations between host microbiome and inflammation suggest role for host microbiome in driving COVID-19 disease severityRachel MacCann, Tarini Shankar Ghosh, Alejandro Abner Garcia Leon, et al.
Ebiomedicine|February 23, 2025
Development and validation of a quantitative Orthopoxvirus immunoassay to evaluate and differentiate serological responses to Mpox infection and vaccinationJoanne Byrne, Gurvin Saini, Alejandro Garcia-Leon, et al.
Heliyon|August 15, 2024
Early inflammatory profiles predict maximal disease severity in COVID-19: An unsupervised cluster analysisGrace Kenny, Gurvin Saini, Colette Marie Gaillard, et al.
Open Forum Infectious Diseases|September 29, 2025
Antibody Responses are Sustained 2 Years Post-Mpox Infection but not Following Modified Vaccinia Ankara-Bavarian Nordic VaccinationJoanne Byrne, Alejandro Garcia-Leon, Aisling Murphy, et al.
The Journal of Infectious Diseases|June 6, 2018
Macrophage Activation Marker Soluble CD163 Is a Dynamic Marker of Liver Fibrogenesis in Human Immunodeficiency Virus/Hepatitis C Virus CoinfectionAnna Lidofsky, Jacinta A Holmes, Eoin R Feeney, et al.
Journal of Immunology (Baltimore, Md. : 1950)|May 23, 2025
Specific thresholds of circulating antibody titers predict against infection and reduced disease severity in SARS-CoV-2 close contactsJoanne Byrne, Colette Marie Gaillard, Lili Gu, et al.
Frontiers in Immunology|October 2, 2024
Robust and persistent B-cell responses following SARS-CoV-2 vaccine determine protection from SARS-CoV-2 infectionJoanne Byrne, Lili Gu, Alejandro Garcia-Leon, et al.
Nature Communications|November 3, 2023
Distinct receptor binding domain IgG thresholds predict protective host immunity across SARS-CoV-2 variants and timeGrace Kenny, Sophie O'Reilly, Neil Wrigley Kelly, et al.
Pageof 7